Similar results have been reported by others (Garcia‐Saenz et al., 2017), although no correlation between PIK3CA mutation levels and treatment response was observed in two of eight advanced breast cancer patients (Garcia‐Saenz et al., 2017). Here, PIK3CA is linked to breast carcinoma.